Page breadcrumb nav

VAERS Report 2136736

Case Report Section

Détails du rapport Vaer

Âge: 52 ans

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: 1f1008a


Date de réception du rapport
2022-02-24
Date à laquelle le formulaire est complèté
Date de vaccination
2021-11-27
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

headache; postmenopausal bleeding; chills; pyrexia; generalized joint pain; injection site swelling; injection site pain; off label use; interchange of vaccine products; injection site warmth; injection site inflammation; injection site erythema; myalgia; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority-web. regulatory number: nl-lrb-00737392 (ra). a 52 year-old female patient received bnt162b2 (comirnaty), administration date 27nov2021 (lot number: 1f1008a) at the age of 52 years as dose 3 (booster), single for covid-19 immunisation. relevant medical history included: "menstruation (after 18 months not)" (unspecified if ongoing); "grass" (unspecified if ongoing). concomitant medication(s) included: rabeprazol [rabeprazole]; foster [beclometasone dipropionate;formoterol fumarate]. vaccination history included: spikevax (dose 2.), administration date: 02apr2021, for covid-19 immunisation, reaction(s): "general malaise", "fever 39+", "headache", "muscle pain"; spikevax (dose 1.), administration date: 08mar2021, for covid-19 immunisation, reaction(s): "some pain at the puncture site". the following information was reported: off label use (medically significant) with onset 27nov2021, outcome "unknown", described as "off label use"; interchange of vaccine products (medically significant) with onset 27nov2021, outcome "unknown", described as "interchange of vaccine products"; postmenopausal haemorrhage (medically significant) with onset 06dec2021, outcome "recovered" (13dec2021), described as "postmenopausal bleeding"; chills (non-serious) with onset 28nov2021, outcome "recovered", described as "chills"; vaccination site warmth (non-serious) with onset 27nov2021, outcome "recovered", described as "injection site warmth"; vaccination site inflammation (non-serious) with onset 27nov2021, outcome "recovered", described as "injection site inflammation"; vaccination site erythema (non-serious) with onset 27nov2021, outcome "recovered", described as "injection site erythema"; pyrexia (non-serious) with onset 28nov2021, outcome "recovered" (29nov2021), described as "pyrexia"; vaccination site swelling (non-serious) with onset 27nov2021, outcome "recovered", described as "injection site swelling"; vaccination site pain (non-serious) with onset 27nov2021, outcome "recovered", described as "injection site pain"; arthralgia (non-serious) with onset 28nov2021, outcome "recovered" (29nov2021), described as "generalized joint pain"; headache (non-serious), outcome "recovered" (30nov2021), described as "headache"; myalgia (non-serious), outcome "recovered", described as "myalgia". the patient underwent the following laboratory tests and procedures: body temperature: (28nov2021) 38 to 40.5, notes: degrees celsius. therapeutic measures were taken as a result of headache. additional information: the patient had no extensive swelling of vaccinated limb. headache was treated with paracetamol. patient had no previous covid-19 infection. it was mentioned that patient had a normal menstruation as 6 days. no follow-up attempts are possible. no further information is expected

Données de laboratoire
test date: 20211128; test name: pyrexia; result unstructured data: test result:38 to 40.5 centigrade; comments: degrees celsius
Liste des symptômes
chills headache arthralgia pyrexia myalgia interchange of vaccine products vaccination site warmth vaccination site swelling vaccination site inflammation body temperature vaccination site pain vaccination site erythema off label use postmenopausal haemorrhage
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na